Aragen Bioscience

ANTIBODY DISCOVERY

Experts in antigen design and hybridoma development.

In-depth experience from gene synthesis and subcloning to protein expression and purification.

Proven track record for a broad range of in vitro and in vivo models of disease.

Short timelines and high titers at every development stage with CLD services.

A PBSS Event
March 9, 2020, Foster City (Postponed)

Don’t miss our podium presentation at 2:35!

New Resources

Download our new capabilities brochure!

…the data they have generated has been used in regulatory filings to enable clinical trials and has informed our clinical indications…
Hector M Rodriguez, PhD, Hector M Rodriguez, previously head of Analytical Biochemistry, Arresto Biosciences. Currently VP of Biology, BridgeBio Pharma

Aragen Bioscience, Inc. and University of Technology, Sydney Enter Into MoU to Support and Accelerate Biologics R&D in Australia

Aragen Bioscience announces the appointment of Steven Lang, PhD, MBA as Vice President, Biologics

Serum Institute and Aragen Bioscience Announce Collaboration on Vaccine Development

GVK BIO announces the appointment of Axel Schleyer, Ph.D. as Chief Executive Officer, Aragen Bioscience, Inc.

Aragen Bioscience Expands Cell Line Development Services